Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
News

BeOne, Hengrui top list of China’s most powerful drugmakers

Why it’s here: Covers China's biotech competition with a live US policy fight over the COINS outbound investment law and proposed limits on US deals with Chinese drugmakers, which falls within the Biotechnology area's BIOSECURE/China competition scope.

Trace across the board

Item

Connected

2 links

About

  • Trump administration
  • COINS Act

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy